{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:52:27Z","timestamp":1787701947272,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1245\/s10434-017-5834-2","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T05:13:24Z","timestamp":1490159604000},"page":"2259-2265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Preoperative Thrombocytosis Predicts Shortened Survival in Patients with Malignant Peritoneal Mesothelioma Undergoing Operative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy"],"prefix":"10.1245","volume":"24","author":[{"given":"Yue C.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Khashab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Terhune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Richard Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,21]]},"reference":[{"key":"5834_CR1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s10552-009-9328-9","volume":"20","author":"SH Moolgavkar","year":"2009","unstructured":"Moolgavkar SH, Meza R, Turim J. Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973\u20132005. Cancer Causes Control. 2009;20:935\u201344.","journal-title":"Cancer Causes Control."},{"key":"5834_CR2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4149\/neo_2014_053","volume":"61","author":"H Kaya","year":"2014","unstructured":"Kaya H, Sezgi C, Tanrikulu AC, et al. Prognostic factors influencing survival in 35 patients with malignant peritoneal mesothelioma. Neoplasma. 2014;61:433\u201338.","journal-title":"Neoplasma."},{"key":"5834_CR3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1200\/JCO.1983.1.6.386","volume":"1","author":"K Antman","year":"1983","unstructured":"Antman K, Pomfret F, Aisner J, et al. Peritoneal mesothelioma: natural history and response to chemotherapy. J Clin Oncol. 1983;1:386\u201396.","journal-title":"J Clin Oncol."},{"key":"5834_CR4","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1200\/JCO.2003.04.150","volume":"21","author":"AL Feldman","year":"2003","unstructured":"Feldman AL, Libutti SK, Pingpank JF, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol. 2003;21:4560\u201367.","journal-title":"J Clin Oncol."},{"key":"5834_CR5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1245\/s10434-013-3358-y","volume":"21","author":"D Magge","year":"2014","unstructured":"Magge D, Zenati MS, Austin F, et al. Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis. Ann Surg Oncol. 2014;21:1159\u201365.","journal-title":"Ann Surg Oncol."},{"key":"5834_CR6","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1245\/s10434-014-3803-6","volume":"21","author":"JT Miura","year":"2014","unstructured":"Miura JT, Johnston FM, Gamblin TC, Turaga KK. Current trends in the management of malignant peritoneal mesothelioma. Ann Surg Oncol. 2014;21:3947\u201353.","journal-title":"Ann Surg Oncol."},{"key":"5834_CR7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","volume":"153","author":"HR Alexander Jr","year":"2013","unstructured":"Alexander HR, Jr., Bartlett DL, Pingpank JF, et al. Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma. Surgery. 2013;153:779\u201386.","journal-title":"Surgery."},{"key":"5834_CR8","doi-asserted-by":"crossref","unstructured":"Helm JH, Miura JT, Glenn JA, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann Surg Oncol. 2014.","DOI":"10.1245\/s10434-014-3978-x"},{"key":"5834_CR9","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27:6237\u201342.","journal-title":"J Clin Oncol."},{"key":"5834_CR10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/cncr.25555","volume":"117","author":"S Varghese","year":"2011","unstructured":"Varghese S, Chen Z, Bartlett DL, et al. Activation of the phosphoinositide-3-kinase and mammalian target of rapamycin signaling pathways are associated with shortened survival in patients with malignant peritoneal mesothelioma. Cancer. 2011;117:361\u201371.","journal-title":"Cancer."},{"key":"5834_CR11","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.ejca.2013.05.027","volume":"49","author":"D Baratti","year":"2013","unstructured":"Baratti D, Kusamura S, Cabras AD, et al. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Cancer. 2013;49:3140\u201348.","journal-title":"Eur J Cancer."},{"key":"5834_CR12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/PAT.0000000000000181","volume":"46","author":"S Liu","year":"2014","unstructured":"Liu S, Staats P, Lee M, et al. Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73 patients. Pathology. 2014;46:604\u201309.","journal-title":"Pathology."},{"key":"5834_CR13","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1245\/s10434-007-9701-4","volume":"15","author":"NJ Gusani","year":"2008","unstructured":"Gusani NJ, Cho SW, Colovos C, et al. Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center. Ann Surg Oncol. 2008;15:754\u201363.","journal-title":"Ann Surg Oncol."},{"key":"5834_CR14","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/jso.23163","volume":"106","author":"M Ishizuka","year":"2012","unstructured":"Ishizuka M, Nagata H, Takagi K, et al. Preoperative thrombocytosis is associated with survival after surgery for colorectal cancer. J Surg Oncol. 2012;106:887\u201391.","journal-title":"J Surg Oncol."},{"key":"5834_CR15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","volume":"366","author":"RL Stone","year":"2012","unstructured":"Stone RL, Nick AM, McNeish IA, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012;366:610\u201318.","journal-title":"N Engl J Med."},{"key":"5834_CR16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ygyno.2006.07.020","volume":"104","author":"DL Lerner","year":"2007","unstructured":"Lerner DL, Walsh CS, Cass I, et al. The prognostic significance of thrombocytosis in uterine papillary serous carcinomas. Gynecol Oncol. 2007;104:91\u201394.","journal-title":"Gynecol Oncol."},{"key":"5834_CR17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/000313481408000415","volume":"80","author":"SJ Shetty","year":"2014","unstructured":"Shetty SJ, Bathla L, Govindarajan V, et al. Comparison of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with mitomycin or carboplatin for diffuse malignant peritoneal mesothelioma. Am Surg. 2014;80:348\u201352.","journal-title":"Am Surg."},{"key":"5834_CR18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg."},{"key":"5834_CR19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/PAT.0b013e3283631cce","volume":"45","author":"M Lee","year":"2013","unstructured":"Lee M, Alexander HR, Burke A. Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy. Pathology. 2013;45:464\u201373.","journal-title":"Pathology."},{"key":"5834_CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1245\/s10434-006-9169-7","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Brun EA, Cerruto CA, et al. Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Ann Surg Oncol. 2007;14:41\u201349.","journal-title":"Ann Surg Oncol."},{"key":"5834_CR21","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1245\/s10434-015-4962-9","volume":"23","author":"S Kusamura","year":"2016","unstructured":"Kusamura S, Torres Mesa PA, Cabras A, et al. The role of Ki-67 and pre-cytoreduction parameters in selecting diffuse malignant peritoneal mesothelioma (DMPM) patients for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2016;23:1468\u201373.","journal-title":"Ann Surg Oncol."},{"key":"5834_CR22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1245\/s10434-012-2651-5","volume":"20","author":"NP Schaub","year":"2013","unstructured":"Schaub NP, Alimchandani M, Quezado M, et al. A novel nomogram for peritoneal mesothelioma predicts survival. Ann Surg Oncol. 2013;20:555\u201361.","journal-title":"Ann Surg Oncol."},{"key":"5834_CR23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011;11:123\u201334.","journal-title":"Nat Rev Cancer."},{"key":"5834_CR24","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20:576\u201390.","journal-title":"Cancer Cell."},{"key":"5834_CR25","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood-2007-09-113837","volume":"111","author":"JE Italiano Jr","year":"2008","unstructured":"Italiano JE Jr, Richardson JL, Patel-Hett S, et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood. 2008;111:1227\u201333.","journal-title":"Blood."},{"key":"5834_CR26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ajh.21732","volume":"85","author":"JE Peterson","year":"2010","unstructured":"Peterson JE, Zurakowski D, Italiano JE Jr, et al. Normal ranges of angiogenesis regulatory proteins in human platelets. Am J Hematol. 2010;85:487\u20133.","journal-title":"Am J Hematol."},{"key":"5834_CR27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1056\/NEJM199301143280207","volume":"328","author":"CA Dinarello","year":"1993","unstructured":"Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med. 1993;328:106\u201313.","journal-title":"N Engl J Med."},{"key":"5834_CR28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s13277-010-0078-9","volume":"31","author":"J Kaur","year":"2010","unstructured":"Kaur J, Sanyal SN. PI3-kinase\/Wnt association mediates COX-2\/PGE(2) pathway to inhibit apoptosis in early stages of colon carcinogenesis: chemoprevention by diclofenac. Tumour Biol. 2010;31:623\u201331.","journal-title":"Tumour Biol."},{"key":"5834_CR29","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1245\/s10434-015-4965-6","volume":"23","author":"S Judge","year":"2016","unstructured":"Judge S, Thomas P, Govindarajan V, et al. Malignant peritoneal mesothelioma: characterization of the inflammatory response in the tumor microenvironment. Ann Surg Oncol. 2016;23:1496\u2013500.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-017-5834-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-5834-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-5834-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T06:26:03Z","timestamp":1601792763000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-017-5834-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,21]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["5834"],"URL":"https:\/\/doi.org\/10.1245\/s10434-017-5834-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,21]]}}}